Marks G, Mohiuddin M M, Masoni L, Pecchioli L
Division of Colorectal Surgery, Comprehensive Rectal Cancer Center, Philadelphia, Pennsylvania 19107.
Dis Colon Rectum. 1990 Sep;33(9):735-9. doi: 10.1007/BF02052317.
Faced with the responsibility of treating patients with invasive distal rectal cancer who were medically unacceptable for the indicated radical surgery, a prospective study was initiated in which high dose preoperative radiation and full-thickness local excision were used. High dose preoperative radiation permitted full-thickness local excision of select cancers, which, by conventional standards, otherwise would have required radical surgery and permanent colostomy. Feasibility was measured on the basis of safety of the technique, control of the cancer, and the quality of anal sphincter function expected. Patients were selected initially because of their predicted inability to tolerate radical surgery, but indications were broadened to include those whose tumors had completely disappeared after irradiation. From 1984 to 1988, 20 patients underwent 21 operative procedures for cancers located between 0 and 7 cm from the anorectal ring. This report is concerned with the 14 patients of this group who were observed for a minimum of 24 months. High-dose preoperative radiation was administered for a total dose of 4500 cGy. Excision and repair were performed 4 to 6 weeks after completion of radiation therapy. Full-thickness disc or hemicircumferential excision was accomplished by transanal, transsphincteric, and transsacral techniques, which included, in several instances, excision of the sphincter mechanism and perineal body, and/or the vaginal wall. Full-thickness local excision after high-dose radiation therapy for rectal cancers has never been reported. Follow-up observation ranged from 24 to 48 months with a median of 31 months. Rectal reservoir function and sphincter control were good in 13 patients. Local recurrence developed in three patients (21 percent), two of whom had postradiation therapy B2 mucinous cancers. Three-year actuarial rate of local recurrence is 23 percent. One (7 percent) patient died of recurrent disease. Actuarial Kaplan-Meier survival at 3 years is 61 percent. Based on the results of this small, select patient group, high-dose radiation therapy followed by full-thickness local excision appears to be a reasonable option for patients who cannot tolerate radical surgery. This bimodal approach also may serve as an option for those who are good medical risks, but for whom sphincter preservation is at stake, and to whom radical surgery offers limited benefits.
面对治疗那些因身体状况而无法接受根治性手术的低位直肠癌患者的责任,我们开展了一项前瞻性研究,采用高剂量术前放疗和全层局部切除的方法。高剂量术前放疗使得部分癌症能够进行全层局部切除,按照传统标准,这些癌症原本需要进行根治性手术并永久性结肠造口。我们根据该技术的安全性、癌症的控制情况以及预期的肛门括约肌功能质量来衡量其可行性。最初选择患者是因为预计他们无法耐受根治性手术,但后来适应症范围扩大到包括那些肿瘤在放疗后完全消失的患者。1984年至1988年期间,20例患者因距肛门直肠环0至7厘米处的癌症接受了21次手术。本报告关注的是该组中至少观察了24个月的14例患者。高剂量术前放疗的总剂量为4500 cGy。放疗结束后4至6周进行切除和修复。全层圆盘状或半环状切除通过经肛门、经括约肌和经骶骨技术完成,在某些情况下,包括切除括约肌结构和会阴体以及/或者阴道壁。此前从未有过关于高剂量放疗后直肠癌全层局部切除的报道。随访观察时间为24至48个月,中位数为31个月。13例患者的直肠贮便功能和括约肌控制良好。3例患者(21%)出现局部复发,其中2例为放疗后B2黏液腺癌。3年局部复发的精算率为23%。1例(7%)患者死于复发性疾病。3年的Kaplan-Meier精算生存率为61%。基于这个小范围特定患者群体的结果,对于无法耐受根治性手术的患者,高剂量放疗后进行全层局部切除似乎是一个合理的选择。这种双峰治疗方法对于那些身体状况良好但括约肌保留至关重要且根治性手术益处有限的患者也可能是一种选择。